The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
Open accessAbstract
The amyloidoses are a group of systemic diseases characterized by organ deposition of misfolded protein fragments of diverse origins. The natural history of the disease, involvement of other organs, and treatment options vary significantly based on the protein of origin. In AL amyloidosis, amyloid protein is derived from immunoglobulin light chains, and most often involves the kidneys and the heart. ATTR amyloidosis is categorized as mutant or wild-type depending on the genetic sequence of the transthyretin (TTR) protein produced by the liver. Wild-type ATTR amyloidosis mainly involves the heart, although the reported occurrence of bilateral carpal tunnel syndrome, spinal stenosis and biceps tendon rupture in these patients speaks to more generalized protein deposition. Mutant TTR is marked by cardiac and/or peripheral nervous system involvement. Cardiac involvement is associated with symptoms of heart failure, and dictates the clinical course of the disease. Cardiac amyloidosis can be diagnosed noninvasively by echocardiography, cardiac MRI, or nuclear scintigraphy. Endomyocardial biopsy may be needed in the case of equivocal imaging findings or discordant data. Treatment is aimed at relieving congestive symptoms and targeting the underlying amyloidogenic process. This includes anti-plasma cell therapy in AL amyloidosis, and stabilization of the TTR tetramer or inhibition of TTR protein production in ATTR amyloidosis. Cardiac transplantation can be considered in highly selected patients in tandem with therapy aimed at suppressing the amyloidogenic process, and appears associated with durable long term survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationMolecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Mehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Kumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Colby, C., Laumann, K., Zeldenrust, S. R., Leung, N., Dingli, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5724 · Cited by 1,137
Review: History of the Amyloid Fibril
Sipe, J. D., & Cohen, A. S. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4221 · Cited by 1,054
Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.029 · Cited by 985
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Maceira, A. M., Joshi, J., Prasad, S. K., Moon, J. C., Perugini, E., Harding, I., Sheppard, M. N., Poole-Wilson, P. A., Hawkins, P. N., & Pennell, D. J. (2005) · Circulation · doi:10.1161/01.cir.0000152819.97857.9d · Cited by 982
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Grogan, M., Scott, C. G., Kyle, R. A., Zeldenrust, S. R., Gertz, M. A., Lin, G., Klarich, K. W., Miller, W. L., Maleszewski, J. J., & Dispenzieri, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.033 · Cited by 763
Transthyretin (TTR) Cardiac Amyloidosis
Ruberg, F. L., & Berk, J. L. (2012) · Circulation · doi:10.1161/circulationaha.111.078915 · Cited by 708
Self-citationRepurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
Berk, J. L., Suhr, O. B., Obici, L., Sekijima, Y., Zeldenrust, S. R., Yamashita, T., Heneghan, M. A., Gorevic, P. D., Litchy, W. J., Wiesman, J. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.283815 · Cited by 708
Kyle, R., Linos, A., Beard, C., Linke, R., Gertz, M., O'Fallon, W., & Kurland, L. (1992) · Blood · doi:10.1182/blood.v79.7.1817.1817 · Cited by 657
AL (Light-Chain) Cardiac Amyloidosis
Falk, R. H., Alexander, K. M., Liao, R., & Dorbala, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.053 · Cited by 649
Fontana, M., Pica, S., Reant, P., Abdel-Gadir, A., Treibel, T. A., Banypersad, S. M., Maestrini, V., Barcella, W., Rosmini, S., Bulluck, H., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016567 · Cited by 626
Holmgren, G., Steen, L., Suhr, O., Ericzon, B.-G., Groth, C.-G., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)93127-m · Cited by 579
Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis
Syed, I. S., Glockner, J. F., Feng, D., Araoz, P. A., Martinez, M. W., Edwards, W. D., Gertz, M. A., Dispenzieri, A., Oh, J. K., Bellavia, D., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.09.023 · Cited by 545
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
Jaccard, A., Moreau, P., Leblond, V., Leleu, X., Benboubker, L., Hermine, O., Recher, C., Asli, B., Lioure, B., Royer, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070484 · Cited by 519
Frequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
Gertz, M. A., Benson, M. D., Dyck, P. J., Grogan, M., Coelho, T., Cruz, M., Berk, J. L., Plante-Bordeneuve, V., Schmidt, H. H. J., & Merlini, G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.075 · Cited by 475
Brenner, D. A., Jain, M., Pimentel, D. R., Wang, B., Connors, L. H., Skinner, M., Apstein, C. S., & Liao, R. (2004) · Circulation Research · doi:10.1161/01.res.0000126569.75419.74 · Cited by 450
Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.
Costa, P. P., Figueira, A. S., & Bravo, F. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4499 · Cited by 427
Castano, A., Haq, M., Narotsky, D. L., Goldsmith, J., Weinberg, R. L., Morgenstern, R., Pozniakoff, T., Ruberg, F. L., Miller, E. J., Berk, J. L., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2839 · Cited by 424
Self-citationTherapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
Richards, D. B., Cookson, L. M., Berges, A. C., Barton, S. V., Lane, T., Ritter, J. M., Fontana, M., Moon, J. C., Pinzani, M., Gillmore, J. D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504942 · Cited by 378
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
González-López, E., Gagliardi, C., Dominguez, F., Quarta, C. C., de Haro-del Moral, F. J., Milandri, A., Salas, C., Cinelli, M., Cobo-Marcos, M., Lorenzini, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx043 · Cited by 376
Mikhael, J. R., Schuster, S. R., Jimenez-Zepeda, V. H., Bello, N., Spong, J., Reeder, C. B., Stewart, A. K., Bergsagel, P. L., & Fonseca, R. (2012) · Blood · doi:10.1182/blood-2011-11-390930 · Cited by 375
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement
Murtagh, B., Hammill, S. C., Gertz, M. A., Kyle, R. A., Tajik, A. J., & Grogan, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.028 · Cited by 330
Connors, L. H., Sam, F., Skinner, M., Salinaro, F., Sun, F., Ruberg, F. L., Berk, J. L., & Seldin, D. C. (2016) · Circulation · doi:10.1161/circulationaha.115.018852 · Cited by 324
Self-citationSuhr, O. B., Coelho, T., Buades, J., Pouget, J., Conceicao, I., Berk, J., Schmidt, H., Waddington-Cruz, M., Campistol, J. M., Bettencourt, B. R., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0326-6 · Cited by 321 · cited 1×
“The siRNA patisiran (ALN-TTR02; Alnylam, Cambridge, MA) has been associated with significant reductions in serum TTR levels in a phase 2 study of patients with familial amyloid polyneuropathy, without serious adverse events (74).”
BackgroundImaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography
Dorbala, S., Vangala, D., Semer, J., Strader, C., Bruyere, J. R., Di Carli, M. F., Moore, S. C., & Falk, R. H. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2787-6 · Cited by 316
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
Feng, D., Edwards, W. D., Oh, J. K., Chandrasekaran, K., Grogan, M., Martinez, M. W., Syed, I. I., Hughes, D. A., Lust, J. A., Jaffe, A. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697763 · Cited by 305
Buss, S. J., Emami, M., Mereles, D., Korosoglou, G., Kristen, A. V., Voss, A., Schellberg, D., Zugck, C., Galuschky, C., Giannitsis, E., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.043 · Cited by 286
Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Feng, D., Syed, I. S., Martinez, M., Oh, J. K., Jaffe, A. S., Grogan, M., Edwards, W. D., Gertz, M. A., & Klarich, K. W. (2009) · Circulation · doi:10.1161/circulationaha.108.785014 · Cited by 283
Ruberg, F. L., Maurer, M. S., Judge, D. P., Zeldenrust, S., Skinner, M., Kim, A. Y., Falk, R. H., Cheung, K. N., Patel, A. R., Pano, A., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.04.015 · Cited by 261
Self-citationAustin, B. A., Tang, W. H. W., Rodriguez, E. R., Tan, C., Flamm, S. D., Taylor, D. O., Starling, R. C., & Desai, M. Y. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.08.008 · Cited by 260
Evolving landscape in the management of transthyretin amyloidosis
Hawkins, P. N., Ando, Y., Dispenzeri, A., Gonzalez-Duarte, A., Adams, D., & Suhr, O. B. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1068949 · Cited by 243
Cardiac amyloidosis: Updates in diagnosis and management
Mohty, D., Damy, T., Cosnay, P., Echahidi, N., Casset-Senon, D., Virot, P., & Jaccard, A. (2013) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2013.06.051 · Cited by 229
Cyrille, N. B., Goldsmith, J., Alvarez, J., & Maurer, M. S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.026 · Cited by 218
Use of Abdominal Fat Tissue Aspirate in the Diagnosis of Systemic Amyloidosis
Libbey, C. A. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.8.1549 · Cited by 208
Liu, D., Hu, K., Niemann, M., Herrmann, S., Cikes, M., Störk, S., Gaudron, P. D., Knop, S., Ertl, G., Bijnens, B., et al. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.000683 · Cited by 198
Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis
LIN, G., DISPENZIERI, A., KYLE, R., GROGAN, M., & BRADY, P. A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12123 · Cited by 188
Cardoso, I., Martins, D., Ribeiro, T., Merlini, G., & Saraiva, M. J. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-74 · Cited by 184
Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African–Americans
Jacobson, D. R., Alexander, A. A., Tagoe, C., & Buxbaum, J. N. (2015) · Amyloid · doi:10.3109/13506129.2015.1051219 · Cited by 183
11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis
Lee, S.-P., Lee, E. S., Choi, H., Im, H.-J., Koh, Y., Lee, M.-H., Kwon, J.-H., Paeng, J. C., Kim, H.-K., Cheon, G. J., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2014.09.018 · Cited by 171
Shin, S. C., & Robinson‐Papp, J. (2012) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.21352 · Cited by 168
Ferreira, N., Saraiva, M. J., & Almeida, M. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.06.030 · Cited by 164
Ruberg, F. L., Appelbaum, E., Davidoff, R., Ozonoff, A., Kissinger, K. V., Harrigan, C., Skinner, M., & Manning, W. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.105 · Cited by 163
Self-citationDoxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model
Cardoso, I., & Saraiva, M. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-4509com · Cited by 158
Progression of transthyretin amyloid neuropathy after liver transplantation
Liepnieks, J. J., Zhang, L. Q., & Benson, M. D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ea15d4 · Cited by 158
Diflunisal for ATTR Cardiac Amyloidosis
Castaño, A., Helmke, S. T., Alvarez, J., Delisle, S., & Maurer, M. S. (2012) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2012.00303.x · Cited by 156
Merlini, G., Planté‐Bordeneuve, V., Judge, D. P., Schmidt, H., Obici, L. P., Perlini, S., Packman, J., Tripp, T. J., & Grogan, D. R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9512-x · Cited by 141
Guan, J., Mishra, S., Qiu, Y., Shi, J., Trudeau, K. M., Las, G., Liesa, M., Shirihai, O. S., Connors, L. H., Seldin, D. C., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404190 · Cited by 141
Prognostic implication of relative regional strain ratio in cardiac amyloidosis
Senapati, A., Sperry, B. W., Grodin, J. L., Kusunose, K., Thavendiranathan, P., Jaber, W. A., Collier, P. H., Hanna, M. A., Popović, Z., & Phelan, D. M. J. (2016) · Heart · doi:10.1136/heartjnl-2015-308657 · Cited by 140
Ackermann, E. J., Guo, S., Booten, S. L., Alvarado, L., Benson, M. D., Hughes, S. G., & Monia, B. P. (2012) · Amyloid · doi:10.3109/13506129.2012.673140 · Cited by 139
Left Ventricular Systolic Dysfunction Precipitated by Verapamil in Cardiac Amyloidosis
Pollak, A., & Falk, R. H. (1993) · CHEST Journal · doi:10.1378/chest.104.2.618 · Cited by 124
Hamon, D., Algalarrondo, V., Gandjbakhch, E., Extramiana, F., Marijon, É., Elbaz, N., Selhane, D., Dubois‐Randé, J., Teíger, E., Planté‐Bordeneuve, V., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.254 · Cited by 104
Sperry, B. W., Ikram, A., Hachamovitch, R., Valent, J. N., Vranian, M. N., Phelan, D. M. J., & Hanna, M. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.593 · Cited by 94
Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins
Migrino, R. Q., Truran, S., Gutterman, D. D., Franco, D. A., Bright, M., Schlundt, B., Timmons, M. A., Motta, A. J., Phillips, S. A., & Hari, P. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00503.2011 · Cited by 92
Madan, S., Kumar, S. K., Dispenzieri, A. A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Dingli, D., Rajkumar, S. V., Hogan, W. J., Leung, N., et al. (2011) · Blood · doi:10.1182/blood-2011-07-370031 · Cited by 89
Skinner, M. M., & Cohen, A. S. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)90764-6 · Cited by 86
Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity
Alhamadsheh, M. M., Connelly, S., Cho, A., Reixach, N., Powers, E. T., Pan, D. W., Wilson, I. A., Kelly, J. W., & Graef, I. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002473 · Cited by 86
Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis
Gilstrap, L. G., Niehaus, E. D., Malhotra, R. K., Ton, V., Watts, J. A., Seldin, D. C., Madsen, J. C., & Semigran, M. J. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.09.004 · Cited by 80
Macedo, B., Batista, A. R., Ferreira, N., Almeida, M. R., & Saraiva, M. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.05.005 · Cited by 70
Edwards, C. V., Gould, J., Langer, A. L., Mapara, M. Y., Radhakrishnan, J., Maurer, M. S., Raza, S., Mears, J. G., Wall, J. S., Solomon, A., et al. (2017) · Amyloid · doi:10.1080/13506129.2017.1292900 · Cited by 68
Bhatti, S., Watts, E., Syed, F., Vallurupalli, S., Pandey, T., Jambekar, K., Mazur, W. M., & Hakeem, A. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew101 · Cited by 51
Piper, C., Butz, T., Farr, M., Faber, L., Oldenburg, O., & Horstkotte, D. (2010) · Amyloid · doi:10.3109/13506121003619310 · Cited by 39
Genotype, echocardiography, and survival in familial transthyretin amyloidosis
Arruda-Olson, A. M., Zeldenrust, S. R., Dispenzieri, A. A., Gertz, M. A., Miller, F. A., Bielinski, S. J., Klarich, K. W., Scott, C. G., & Grogan, M. A. (2013) · Amyloid · doi:10.3109/13506129.2013.845745 · Cited by 37
Huang, J., Zhao, S., Chen, Z., Zhang, S., & Lu, M. (2015) · International Heart Journal · doi:10.1536/ihj.15-005 · Cited by 30
Cited by
Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01760-6 · Cited by 484
Self-citationSystemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review
Gertz, M. A., & Dispenzieri, A. (2020) · JAMA · doi:10.1001/jama.2020.5493 · Cited by 366
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
Witteles, R. M., Bokhari, S., Damy, T., Elliott, P. M., Falk, R. H., Fine, N. M., Gospodinova, M., Obici, L., Rapezzi, C., & Garcia-Pavia, P. (2019) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.04.010 · Cited by 351
Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2021) · Circulation: Cardiovascular Imaging · doi:10.1161/hci.0000000000000029 · Cited by 275
Self-citationThe Dual-Tree Complex Wavelet Transform: A New Efficient Tool For Image Restoration And Enhancement
Kingsbury, N. (1998) · doi:10.5281/zenodo.36900 · Cited by 272
Metadata
- Authors
- Siddiqi, O. K., & Ruberg, F. L.
- Venue
- Trends in Cardiovascular Medicine
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 28
- Issue
- 1
- Pages
- 10-21
- ISSN
- 1050-1738 (ISSN-L)
- OpenAlex
- W2735021378
- Cited by
- 333
- References
- 70
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.